WCN 2026
28 - 31 March 2026
Mechanistic kidney effects of semaglutide by baseline SGLT2i use in type 2 diabetes: a post-hoc analysis of the REMODEL trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.